|
|
Effect of Splenectomy and Pericardial Devascularization in the Treatment of Hepatocirrhosis with Portal Hypertension and the Influence on Liver Function of Patients |
XIE Xiang, et al |
The People's Hospital of Wuhan University, Hubei Wuhan 430060, China |
|
|
Abstract Objective: To explore the effect of splenectomy and pericardial devascularization in the treatment of portal hypertension with liver cirrhosis and its effect on liver function in patients. Methods: A total of 78 patients with portal hypertension were treated in our hospital from March 2016 to May 2017. All the patients were divided into two groups according to random number table, each group of 39 cases. The patients in the control group were treated with traditional open splenectomy and pericardial devascularization. And the patients in the observation group were treated with laparoscopic splenectomy and pericardial devascularization. The clinical indicators, liver function indexes and complications were compared between the two groups. Results: The intraoperative blood loss, visual analogue scale (VAS) score, bowel function recovery time and hospitalization time were less in the observation group, and the operation time was longer and the difference was statistically significant(P <0.05).There was no significant difference in the levels of prothrombin time (PT), albumin (ALB), alanine aminotransferase (ALT) and total bilirubin (TBIL) between the two groups before operation (P> 0.05).The levels of PT, ALB, ALT and TBIL in the two groups were significantly better than those before operation (P <0.05).The levels of PT, ALT and TBIL in the observation group were significantly higher than those in the control group, the ALB level was lower (P <0.05).The incidence of postoperative complications was 5.13% (2/39) in the observation group significantly higher than that in the control group (23.08%, 9/39), the difference was statistically significant (P <0.05). Conclusion: Laparoscopic resection of pericardial cardiomyocytes can reduce the amount of intraoperative blood loss, reduce the incidence of complications, shorten the recovery time and hospital stay in patients with cirrhotic portal hypertension, improve liver function.
|
|
|
|
|
[1] 包汉康,韦秀丽.手助腹腔镜与开腹脾切除贲门周围血管离断术治疗肝硬化门脉高压症的疗效比较[J].临床军医杂志,2016,44(1):92~94,97. [2] 肖旭,蔡卫华,胡进勇,等.选择性贲门周围血管离断术对门脉高压症术后门静脉血栓形成的临床研究[J].肝胆外科杂志,2015,23(2):135~137. [3] 吴连杰,韩丽娟.肝硬化疾病诊断中的生化检验项目及价值探讨[J].湖南师范大学学报(医学版),2015,12(3):123~125. [4] 石恒彦.腹腔镜下巨脾切除联合贲门周围血管离断术治疗肝硬化门静脉高压症效果观察[J].河南医学研究,2017,26(2):313~314. [5] 张雄,阴继凯,贺加星,等.腹腔镜与开腹术治疗120例门脉高压症患者的临床效果研究[J].现代生物医学进展,2016,16(36):7140~7142,7146. [6] 张安元,康世洲,吴涯昆.完全腹腔镜脾切除联合贲门周围血管离断术在肝硬化门脉高压症中的应用[J].腹腔镜外科杂志,2015,20(8):570~573. [7] 肖旭,蔡卫华,胡进勇,等.选择性贲门周围血管离断术对门脉高压症术后门静脉血栓形成的临床研究[J].肝胆外科杂志,2015,23(2):135~137. [8] 马万里,谢永铮,张军杰,等.腹腔镜巨脾切除加断流术治疗肝硬化门静脉高压症27例分析[J].重庆医学,2014,43(3):348~349. [9] 刘新文.腹腔镜下巨脾切除联合贲门周围血管离断术治疗肝硬化门静脉高压30例[J].中国现代普通外科进展,2016,19(4):310~312. [10] 余灵祥,张绍庚,郭晓东,等.2200例门静脉高压症患者行脾切除贲门周围血管离断术的近期疗效观察[J].现代生物医学进展,2014,14(10):1883~1885,1860. [11] 温治强,宋越,张耀明,等.腹腔镜脾切除联合贲门周围血管离断术治疗肝硬化门静脉高压症[J].腹腔镜外科杂志,2016,21(5):369~372. [12] Licinio R,Losurdo G,Carparelli S,et al.Helicobacter pylori,liver cirrhosis,and portal hypertension:an updated appraisal[J].Immunopharmacol Immunotoxicol,2016,38(6):408~413. [13] 马宁罗晓,孙宝霞,蒋亚新,等.肝硬化门脉高压症术后门静脉血栓形成的预测[J].中国实验诊断学,2017,21(4):660~662. |
|
|
|